Wednesday, May 31, 2017

Republican Senate Candidate Dom Gentile Announces Support for #MedicalCannabis Legislation

Republican Senate Candidate Dom Gentile Announces Support for #MedicalCannabis Legislation


BIRMINGHAM, Ala. - May 31, 2017 (Investorideas.com Newswire) Alabama candidate for U.S. Senate, Dom Gentile, today announced his support for medical cannabis, and is adding this issue to his campaign platform at gentileforsenate.com.
"I have recently met with dozens of people who are stricken with medical conditions such as epilepsy, seizures, severe autism, Alzheimer's and MS. Many of them have symptoms that can be relieved by cannabis that is specifically formulated for medical use. As I listened to the passionate pleas of these patients and their families, and understood how this can help them, I became a believer that something needed to be done at the federal level," said Gentile. "Medical cannabis is listed as a Schedule 1 controlled substance under the Controlled Substances Act of 1970. It is in the same class as heroin and LSD, and that is absurd. I am calling for the FDA and the DEA to immediately re-classify cannabis for medical use and allow the states to decide how to dispense the drug."

Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks




Watch the 420 Cannabis Investor video

 

More Info:



This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


No comments:

Post a Comment